Stockholm - Free Realtime Quote SEK

Boule Diagnostics AB (publ) (BOUL.ST)

8.30
0.00
(0.00%)
As of 1:35:02 PM GMT+2. Market Open.
Loading Chart for BOUL.ST
  • Previous Close 8.30
  • Open 8.30
  • Bid 8.18 x --
  • Ask 8.32 x --
  • Day's Range 8.22 - 8.60
  • 52 Week Range 6.50 - 11.50
  • Volume 24,064
  • Avg. Volume 49,002
  • Market Cap (intraday) 322.315M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) --
  • EPS (TTM) -8.16
  • Earnings Date Jul 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 6, 2022
  • 1y Target Est 10.50

Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.

www.boule.com

200

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BOUL.ST

View More

Performance Overview: BOUL.ST

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

BOUL.ST
7.57%
OMX Stockholm 30 Index (^OMX)
1.92%

1-Year Return

BOUL.ST
19.42%
OMX Stockholm 30 Index (^OMX)
3.68%

3-Year Return

BOUL.ST
69.32%
OMX Stockholm 30 Index (^OMX)
25.83%

5-Year Return

BOUL.ST
81.53%
OMX Stockholm 30 Index (^OMX)
69.44%

Compare To: BOUL.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BOUL.ST

View More

Valuation Measures

As of 5/14/2025
  • Market Cap

    322.31M

  • Enterprise Value

    503.01M

  • Trailing P/E

    --

  • Forward P/E

    6.92

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.61

  • Price/Book (mrq)

    1.86

  • Enterprise Value/Revenue

    0.96

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -60.48%

  • Return on Assets (ttm)

    7.67%

  • Return on Equity (ttm)

    -94.39%

  • Revenue (ttm)

    523.56M

  • Net Income Avi to Common (ttm)

    -316.68M

  • Diluted EPS (ttm)

    -8.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    20M

  • Total Debt/Equity (mrq)

    116.01%

  • Levered Free Cash Flow (ttm)

    23.47M

Research Analysis: BOUL.ST

View More

People Also Watch